Nascent Biotech (NBIO) 8-K Changes in Registrant's Certifying Accountant

EXHIBIT 16.1

December 10, 2019

U.S. Securities and Exchange Commission

450 Fifth Street, N.W.

Washington, DC 20549

RE:	Nascent Biotech, Inc.
File No.:	000-55399

We have read the statements under Item 4.01 of the Current Report on Form 8-K to be filed with the Securities and Exchange Commission on December 10, 2019 regarding the change of auditors. We agree with all statements pertaining to us.

We have no basis to agree or disagree with statements pertaining to the successor accountants.

MaloneBailey, LLP

www.malonebailey.com

Houston, Texas